96-10893. GRAS Status of Propylene Glycol; Exclusion of Use in Cat Food  

  • [Federal Register Volume 61, Number 86 (Thursday, May 2, 1996)]
    [Rules and Regulations]
    [Pages 19542-19544]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-10893]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Parts 500, 582, and 589
    
    [Docket No. 94G-0239]
    
    
    GRAS Status of Propylene Glycol; Exclusion of Use in Cat Food
    
    AGENCY: Food and Drug Administration, HHS.
    
    
    [[Page 19543]]
    
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to exclude from generally recognized as safe (GRAS) 
    status the use of propylene glycol (PG) in or on cat food. This final 
    action is based on FDA's review of currently available information 
    which has raised significant questions about the safety of this use. 
    Semimoist pet foods containing PG were not in existence when the GRAS 
    status of PG for use in animal feeds was established, thus the agency's 
    prior GRAS determination does not apply to the newly intended uses of 
    PG.
    
    EFFECTIVE DATE: June 3, 1996.
    FOR FURTHER INFORMATION CONTACT: David A. Dzanis, Center for Veterinary 
    Medicine (HFV-222), Food and Drug Administration, 7500 Standish Pl., 
    Rockville, MD 20855, 301-827-0169.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        In the Federal Register of May 10, 1995 (60 FR 24808), FDA issued a 
    proposed rule to amend the animal drug regulations to exclude from GRAS 
    status the use of PG in or on cat food. In the proposed rule of May 10, 
    1995, the regulatory history of PG was reviewed as well as the last 13 
    years of scientific literature on the safety of PG in cat food. FDA 
    concluded that there are significant questions about the safety of PG 
    in cat food. FDA also concluded that PG is not GRAS as an ingredient of 
    cat food, and the use is not subject to a prior sanction. When used in 
    or on cat food, PG is deemed to be a food additive, subject to section 
    409 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 
    348), and its use in cat food must be in accordance with a published 
    food additive regulation. Comments by the public on the proposed rule 
    were requested to be submitted by July 24, 1995.
    
    II. Comments on the Proposed Rule
    
        In response to publication of the proposed rule to amend the GRAS 
    status of PG to exclude its use in cat foods, three parties submitted 
    comments: Two manufacturers of PG, and one pet food industry 
    association. One party offered unconditional support of the proposed 
    rule. The other two parties offered comments to amend the proposed rule 
    to allow for limited use of PG.
        1. One comment argued for the need for PG as a carrier for 
    antioxidants added to cat food. Antioxidants are needed to prevent 
    oxidation of unsaturated fats and other components of cat foods, which 
    could adversely affect nutritional and organoleptic properties of the 
    products. The amount of PG in the finished food stemming from such use 
    was estimated to be 0.0009 to 0.007 percent (9 to 70 milligrams per 
    kilogram (mg/kg).
        FDA agrees that the judicious use of antioxidants serves a vital 
    role in preserving the freshness and quality of cat foods. FDA has 
    previously reviewed data relative to the use of PG as an antioxidant 
    carrier and estimates the ``worst case'' inclusion level in the 
    finished food to be less than 0.02 percent (200 mg/kg) on a dry matter 
    basis. In such cases, PG would no longer serve any technical or 
    functional effect in the finished food and would be present at 
    insignificant levels. Regardless, no argument was made that PG was 
    unique in its ability to serve as an antioxidant carrier, or that a 
    suitable substitute for PG was unavailable or impractical.
        2. Two comments argued that an establishment of an adequate safety 
    margin below the known ``no-observed-effect-level'' (NOEL) for cats and 
    kittens should allow for limited use of PG. The most conservative known 
    NOEL for growing kittens is 0.135 percent (1,350 mg/kg), well below the 
    expected levels of inclusion resulting from its use as an antioxidant 
    carrier. Thus, establishment of an acceptable daily intake level at 
    some level below the NOEL should allow for safe use of PG in cat foods.
        FDA agrees that the estimated level of PG in cat foods resulting 
    from its use as an antioxidant carrier appears to offer an adequate 
    margin of safety relative to the known NOEL. Thus, FDA's primary 
    regulatory concern at this time is limited to cat foods containing PG 
    at levels exceeding 0.02 percent. However, FDA does not believe that a 
    specific level of PG for inclusion in cat food can be based solely on 
    the existing NOEL. This is because the NOEL was determined on the basis 
    of the presence or absence of Heinz bodies in a study performed in 
    1979, and it has not been subject to reassessment using the more 
    sensitive methods available today to evaluate possible adverse effects. 
    The more current studies using more specific indicators of red blood 
    cell damage did not look at effects near the existing NOEL, nor did 
    they establish an NOEL in and of themselves. Also, although data are 
    known on the effects of PG on adult cats and growing kittens, there are 
    no data on the potential effects of PG on other life stages of cats. 
    For example, the possible congenital effects stemming from the feeding 
    of PG to pregnant cats has not been adequately assessed.
    
    III. Conclusion
    
        The proposed rule has not been changed as a result of received 
    comments. Therefore, the final rule provides that PG for use in cat 
    food is not GRAS and is a food additive subject to section 409 of the 
    act.
    
    IV. Environmental Impact
    
        The agency has carefully considered the potential environmental 
    effects of this action. FDA has concluded that the action will not have 
    a significant impact on the human environment, and that an 
    environmental impact statement is not required. The agency's finding of 
    no significant impact and the evidence supporting that finding, 
    contained in an environmental assessment, may be seen in the Dockets 
    Management Branch (HFA-305), Food and Drug Administration, 12420 
    Parklawn Dr., rm. 1-23, Rockville, MD 20857, between 9 a.m. and 4 p.m., 
    Monday through Friday.
    
    V. Analysis of Impacts
    
        FDA has examined the impacts of the final rule under Executive 
    Order 12866 and the Regulatory Flexibility Act (Pub. L. 96-354). 
    Executive Order 12866 directs agencies to assess all costs and benefits 
    of available regulatory alternatives and, when regulation is necessary, 
    to select regulatory approaches that maximize net benefits (including 
    potential economic, environmental, public health and safety, and other 
    advantages; distributive impacts; and equity). The agency believes that 
    this final rule is consistent with the regulatory philosophy and 
    principles identified in the Executive Order. In addition, this final 
    rule is not a significant regulatory action as defined by the Executive 
    Order and so is not subject to review under the Executive Order.
        This assessment analyzes the economic effects of this rule to 
    exclude from GRAS status the use of PG in or on cat food. PG is used as 
    a humectant, plasticizer, and microbiological preservative in semimoist 
    cat food. Semimoist cat foods containing PG did not exist when the GRAS 
    status for its use in animal feeds was established, and this GRAS 
    determination does not apply to the newly intended use of PG. Currently 
    available information on the effects of PG demonstrates serious 
    concerns about its safety in cats.
        FDA requested that pet food manufacturers discontinue the use of PG 
    as an ingredient in semimoist cat foods in 1992. The majority of 
    manufacturers in the industry have complied with this request. Agency 
    experts estimate that
    
    [[Page 19544]]
    
    PG is currently used in at most 5 percent of semimoist cat foods and at 
    most 10 percent of cat snacks, which are similar in texture and content 
    to semimoist foods. These usage rates continue to decline.
        FDA estimates of 1993 sales of semimoist cat foods and snacks to 
    U.S. households are $85 million and $53 million, respectively (Neilsen 
    Marketing Research data). Those sales representing semimoist cat foods 
    and cat snacks which contain PG are approximately $9,550 million (5 
    percent of $85 million plus 10 percent of $53 million). The effect of 
    this rule would be to replace these sales with other cat foods and cat 
    snacks not containing PG. Most of the industry has already substituted 
    glycerin for PG in semimoist foods and snacks. It is likely that the 
    remaining portion of the industry would make the substitution of 
    glycerin for PG rather than surrender their share of the semimoist cat 
    food and cat snack market. The cost of this substitution to the 
    production process is expected to be small.
        Purchases of PG by semimoist cat food and cat snack manufacturers 
    represent a very small percentage of total PG sales, estimated at less 
    than 1 percent. Demand for semimoist cat foods has declined 
    considerably since 1987. Although demand for cat snacks continues to 
    grow, its sales are still a small part of the total pet food industry. 
    Thus, the effect of this final rule on PG manufacturers would also be 
    small. The effects of this final rule on small businesses would not be 
    substantial. Although more small sized companies are involved in 
    manufacturing cat snack foods than in semimoist foods, their costs of 
    compliance would not be significant.
        The Regulatory Flexibility Act requires agencies to analyze 
    regulatory options that would minimize any significant impact of a rule 
    on small entities. For the above reasons, the agency certifies that 
    this rule will not have a significant economic impact on a substantial 
    number of small entities. Therefore, under the Regulatory Flexibility 
    Act, no further analysis is required.
    
    VI. Federalism
    
        FDA has analyzed this rule in accordance with the principles and 
    criteria set forth in Executive Order 12612 and has determined that 
    this rule does not warrant the preparation of a Federalism Assessment.
    
    List of Subjects
    
    21 CFR Part 500
    
        Animal drugs, Animal feeds, Cancer, Labeling, Polychlorinated 
    biphenyls (PCB's).
    
    21 CFR Parts 582 and 589
    
        Animal feeds, Animal foods, Food additives.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR parts 
    500, 582, and 589 are amended as follows:
    
    PART 500--GENERAL
    
        1. The authority citation for 21 CFR part 500 continues to read as 
    follows:
    
        Authority: Secs. 201, 301, 402, 403, 409, 501, 502, 503, 512, 
    701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 
    342, 343, 348, 351, 352, 353, 360b, 371).
    
        2. New Sec. 500.50 is added to subpart B to read as follows:
    
    
    Sec. 500.50  Propylene glycol in or on cat food.
    
        The Food and Drug Administration has determined that propylene 
    glycol in or on cat food is not generally recognized as safe and is a 
    food additive subject to section 409 of the Federal Food, Drug, and 
    Cosmetic Act (the act). The Food and Drug Administration also has 
    determined that this use of propylene glycol is not prior sanctioned.
    
    PART 582--SUBSTANCES GENERALLY RECOGNIZED AS SAFE
    
        3. The authority citation for 21 CFR part 582 continues to read as 
    follows:
    
        Authority: Secs. 201, 402, 409, 701 of the Federal Food, Drug, 
    and Cosmetic Act (21 U.S.C. 321, 342, 348, 371).
    
        4. Section 582.1666 is amended by revising paragraph (b) to read as 
    follows:
    
    Sec. 582.1666  Propylene glycol.
    
    * * * * *
        (b) Conditions of use. This substance is generally recognized as 
    safe (except in cat food) when used in accordance with good 
    manufacturing or feeding practice.
    
    PART 589--SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED
    
        5. The authority citation for 21 CFR part 589 continues to read as 
    follows:
    
        Authority: Secs. 201, 402, 409, 701, of the Federal Food, Drug, 
    and Cosmetic Act (21 U.S.C. 321, 342, 348, 371).
    
        6. New Sec. 589.1001 is added to subpart B to read as follows:
    
    Sec. 589.1001  Propylene glycol in or on cat food.
    
        The Food and Drug Administration has determined that propylene 
    glycol in or on cat food has not been shown by adequate scientific data 
    to be safe for use. Use of propylene glycol in or on cat food causes 
    the feed to be adulterated and in violation of the Federal Food, Drug, 
    and Cosmetic Act (the act), in the absence of a regulation providing 
    for its safe use as a food additive under section 409 of the act, 
    unless it is subject to an effective notice of claimed investigational 
    exemption for a food additive under Sec. 570.17 of this chapter, or 
    unless the substance is intended for use as a new animal drug and is 
    subject to an approved application under section 512 of the act or an 
    effective notice of claimed investigational exemption for a new animal 
    drug under part 511 of this chapter.
    
        Dated: April 23, 1996.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 96-10893 Filed 5-1-96; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
6/3/1996
Published:
05/02/1996
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
96-10893
Dates:
June 3, 1996.
Pages:
19542-19544 (3 pages)
Docket Numbers:
Docket No. 94G-0239
PDF File:
96-10893.pdf
CFR: (3)
21 CFR 500.50
21 CFR 582.1666
21 CFR 589.1001